Prognostic Value of Neurometabolic Networks in CRC (PVNM-CRC)

Launched by THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY · Apr 9, 2025

Keywords

ClinConnect Summary

This clinical trial, called PVNM-CRC, is focused on understanding how the brain and gut interact in patients with colorectal cancer (CRC). Researchers believe that the way our brain processes information and communicates with the gut may play a role in the development and spread of CRC. By studying these connections, the trial aims to find new ways to detect CRC earlier and improve treatment options, potentially leading to better outcomes for patients.

To participate in this study, individuals must be at least 18 years old and have rectal cancer. The trial is currently recruiting participants and welcomes both men and women. Those who join can expect to undergo various assessments to help researchers understand the relationship between brain metabolism and CRC. This research could eventually lead to new diagnostic tools and therapies tailored specifically for CRC patients, offering hope for improved management of the disease.

Gender

ALL

Eligibility criteria

• • Male/Female subjects with rectal cancer of at least 18 years of age will be enrolled in this trial.